1. Rusconi W Patenting and licensing of the breast cancer susceptibility genes—BRCA1 and BRCA2. Washington, DC: National Academies, 2005. Available at: http://www.genome.duke.edu/centers/cpg/documents/project1/clinical-genetic-testing/NAS%20Patents%20and%20BRCA%202-11-2005%20%282%29.pdf. Accessed November 18, 2009.
2. National Human Genome Research Institute. Breast cancer information core. Available at: http://research.nhgri.nih.gov/bic/. Accessed September 25, 2008.
3. Architectures of genetic medicine: comparing genetic testing for breast cancer in the USA and UK;Parthasarathy;Soc Stud Med,2005
4. Myriad Genetics U.S. National Cancer Institute Memorandum of understanding. Salt Lake, Utah, Myriad Genetics, 1999.
5. Lewin Group The value of diagnostics: innovation, adoption, and diffusion into health care 2005. Falls Church, VA, Lewin Group, 2005.